Navigation Links
Personal Care Products Council CEO & President Pamela G. Bailey Testifies on FDA Cosmetic Regulation Before U.S. House Committee on Energy and Commerce
Date:5/14/2008

hment registration and drug listing.

"Product safety in a global marketplace is not only a matter of law for our members but also the primary commitment for each of them and for our trade association," said Pamela Bailey. "The Council is a science-based, safety-first organization with a decades-long track record of product safety initiatives that go beyond the requirements of the law."

For nearly 40 years, personal care product companies have invested millions of dollars through the Council in additional safety programs and initiatives to supplement FDA regulations. These initiatives include:

-- The FDA Company Registration Program (VCRP) through which FDA collects

information on manufacturers, packers, and distributors of cosmetic

products in commercial distribution in the U.S.;

-- The Cosmetic Ingredient Review (CIR) -- an independent expert panel of

scientists and physicians that evaluate safety data for the most

commonly-used cosmetic ingredients;

-- The Cosmetic Ingredient Dictionary that has been cited by the FDA as

the primary source of ingredient names for FDA regulations requiring

cosmetic ingredient labeling;

-- Technical Guidelines for the industry that provide information on

microbiological testing, quality assurance, and safety testing;

-- Consumer Commitment Code that requires signing member companies to go

beyond the requirements of the law by agreeing to open their scientific

data and information to FDA scrutiny, to report to FDA serious and

unexpected adverse consumer experiences with a cosmetic product, and to

register their manufacturing establishments and formulas with the FDA;

-- The Establishment of International Consumer Safety Standards through

the International Organization for Standardization (ISO) program;

-- ICCR, a Global Harmonization of Regulations process, is an off
'/>"/>

SOURCE Personal Care Products Council
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. More proof needed of safety and quality of electronic personal health records
2. UPMC Health Plan Launches New Personal Health Record
3. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time
4. £5 million investment in personalized medicines to cut patient deaths
5. Scientists, physicians present latest findings in personalized cancer treatment and prevention
6. Personal chaos in HIV patients lives may be a barrier to regular medical care, UCLA Study Shows
7. The Burn Machine(R) Heats Up Personal Fitness
8. Health Integrated to Showcase Synergy Personal Health Management(R) at DMAA Conference
9. Internet TV Network for Personal Trainers is Launched
10. Triveris Introduces Personal Health Record with Built-in Health Advisor
11. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 1The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 2The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 3Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 1Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 234 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 134 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 234 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 334 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 4